To determine whether treatment with PX-12 prevents IL-6-induced Trx-1 nuclear translocation in CRC cells, HT-29 cells were pre-treated with 5 μM PX-12 for 24 h and then treated with IL-6 (20 ng/mL) for 2 h. The gene discussed is IL6; the disease is colorectal carcinoma.